참고문헌
- Bae JH. 2004. Antimicrobial effect of Portulaca oleracea extracts on food-brone pathogens. J Food Sci Nutr 9:306-311 https://doi.org/10.3746/jfn.2004.9.4.306
- Balck RE, Levine MM, Clements ML, Hughes TP, Blaser M. 1988. Experimental Campylobacter jejuni infection in humans. J Infectious Disease 157:472-479 https://doi.org/10.1093/infdis/157.3.472
- Ballal SA, Gallini CA, Segata N, Huttenhower C, Garrett WS 2011. Host and gut microbiota symbiotic factors: lessons from inflammatory bowel disease and successful symbionts. Cellular Microbiol 13:508-517 https://doi.org/10.1111/j.1462-5822.2011.01572.x
- Bhatnagar S, Singh KD, Sazawal S, Saxena S, Bhan MK. 1998. Efficacy of milk versus yoghurt offered as part of a mixed diet in acute noncholera diarrhea among malnourished children. J Pediatrics 132:999-1003 https://doi.org/10.1016/S0022-3476(98)70398-1
- Demol P. 1994. Human Campylobacteriosis: Clinical and epidermiological aspects. Dairy, Food Environ Sanit 14:314-316
- Franco DA. 1988. Campylobacter species: Considerations for controlling a foodborne pathogen. J Food Prot 51:145-153 https://doi.org/10.4315/0362-028X-51.2.145
- Friedman M. 2007. Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas. Mol Nutr Food Res 51:116-134 https://doi.org/10.1002/mnfr.200600173
- Gonzalez-Sarrias A, Larrosa M, Tomas-Barberan F, Dolara P, Espin JC. 2010. NF-kappa B-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts. Br J Nutr 104:503-512 https://doi.org/10.1017/S0007114510000826
- Huang P, Farkas T, Marionneau S, Zhong W, Ruvoen-Clouet, N, Morrow AL, Altaye M, Pickering LK, Newburg DS, LePendu J, Jiang X. 2003. Noroviruses bind to human ABO and secretor histo-blood group antigens: Identification of 4 distinct strain-specific patterns. J Infectious Diseases 188: 19-31 https://doi.org/10.1086/375742
- Hughey VL, Johnson EA 1987. Antimicrobial activity of lysozyme against bacteria involved in food spoilage and food-bone disease. Appl Environ Microbiol 53:2165-2170
- Larrosa M, Gonzalez-Sarrias A, Yanez-Gascon MJ, Selma MV, Azorin-Orturil M, Toti S, Tomas-Barberan F, Dolara P, Espin JC. 2010. Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. J Nutr Biochem 21:717-725 https://doi.org/10.1016/j.jnutbio.2009.04.012
- Newburg DS, Ruiz-Palacios GM, Altaye M, Chaturvedi P, Meinzen-Derr J, Morrow AL. 2004. Innate protection conferred by fucosylated oligosaccharides of human milk against diarrhea in breastfed infants. Glycobiol 14:253-263 https://doi.org/10.1093/glycob/cwh020
- Newburg DS. 1992. Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. J Clin Invest 90:1984-1991 https://doi.org/10.1172/JCI116078
- Newburg DS. 2000. Oligosaccharides in human milk and bacterial colonization. J Pediatr Gastroenterol Nutr 30:S8-S17 https://doi.org/10.1097/00005176-200003002-00003
- Park SH, Kim DK, Bae JH. 2011. The antioxidant effect of Portulaca oleracea extracts and its antimicrobial activity on Helicobacter pylori. Korean J Food Nutr 24:306-311 https://doi.org/10.9799/ksfan.2011.24.3.306
-
Ruiz-Palacios GM, Cervantes LE, Ramos P, Chavex-Munguia B, Newburg DS. 2003. Campylobacter jejuni binds intestinal H(O) antigen (
$fuc{\alpha}1$ ,2$gal{\beta}1$ ,4glcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. J Biol Chem 278:14112-14120 https://doi.org/10.1074/jbc.M207744200 - Shen Z, Warren CD, Newburg DS. 2003. High-performance capillary electrophoresis of sialylated oligosaccharides of human milk. Anal Biochem 279:37-45
- Sudjana AN, D'Orazio C, Ryan V, Rasool N, Ng J, Islam N, Riley TV, Hammer KA. 2009. Antimicrobial activity of commercial Olea europaea(olive) leaf extract. Int J Antimicro Agents 33:461-463 https://doi.org/10.1016/j.ijantimicag.2008.10.026
- Tan PV, Boda M, Etoa FX. 2010. In vitro and in vivo anti- Helicobacter/Campylobacter activity of the aqueous extract of Enantia chlorantha. Pharmaceutical Biol 48:349-356 https://doi.org/10.3109/13880200903150377
- Wardwell LH, Huttenhower C, Garrett WS. 2011. Current concepts of the intestinal microbiota and the pathogenesis of infection. Curr Infect Dis Rep 13:28-34 https://doi.org/10.1007/s11908-010-0147-7
- Xiang L, Xing D, Wang W, Wang R, Ding Y, Du L. 2005. Alkaloids from Portulaca oleracea L. Phytochem 66:2595-2601 https://doi.org/10.1016/j.phytochem.2005.08.011
피인용 문헌
- Antioxidant, Physiological Activities, and Acetylcholinesterase Inhibitory Activity of Portulaca oleracea Extracts with Different Extraction Methods vol.43, pp.3, 2014, https://doi.org/10.3746/jkfn.2014.43.3.389
- 마치현 부위별 에탄올 추출물의 항산화 활성 vol.34, pp.1, 2019, https://doi.org/10.6116/kjh.2019.34.1.59